Guidelines for implementation of clinical DNA cytometry

Cytometry

Volumn 14, Issue 5, 1993, Pages 472-477

  Shankey, T Vincent ^a   Rabinovitch, Peter S ^b   Bagwell, Bruce ^c   Bauer, Kenneth D ^d   Duque, Ricardo E ^f   Hedley, David W ^h   Mayall, Brian H ^e   Wheeless, Leon ^g  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Genentech ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Physicians Medical Center Carraway   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^h PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CYTOMETRY; DNA CONTENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CLINICAL PROTOCOLS; DNA, NEOPLASM; FLOW CYTOMETRY; HUMAN; NEOPLASMS;

EID: 0027289565     PISSN: 01964763     EISSN: 10970320     Source Type: Journal    
DOI: 10.1002/cyto.990140503     Document Type: Article

References (40)

1. Convention on nomenclature for DNA cytometry
2. Inter‐laboratory comparison of DNA flow cytometric results from paraffin‐embedded breast carcinomas
3. Precision of DNA flow cytometry in interinstitutional analyses
4. Variability in flow cytometric results using identical archival samples
5. An inter‐laboratory assessment of the reproducibility of flow cytometric DNA content analysis of archival tumor samples
6. Different opinions on classification of DNA histograms produced from paraffin‐embedded tissue
7. Comparison of fresh and paraffin‐embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity
8. Comparison of fresh, ethanol‐preserved, and paraffin‐embedded samples in DNA flow cytometry
9. The reproducibility of flow cytometric analyses in human tumors: Methodological aspects
10. Flow cytometric nuclear DNA content of fresh and paraffin‐embedded tissues of breast carcinomas and fibroadenomas
11. Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms
12. Improved preparation technique of cervical carcinoma for flow cytometric DNA analysis with tissue disintegration in hydrochloric acid
13. Evidence for false aneuploid peaks in flow cytometric analysis of paraffin‐embedded tissue
14. Multiparameter deox‐yribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry: Clinopathologic correlations
15. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer
16. Flow cytometric determination of breast tumor heterogeneity
17. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy
18. Intratumoral variations in DNA distribution patterns in mammary adenocarcinomas
19. Variability in DNA measurements in multiple tumor samples of human colonic carcinoma
20. Flow cytometric DNA content analysis in primary lung cancer: comparison of results from fresh and paraffin‐embedded specimens
21. Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder
22. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report
23. The soft agar clonagenicity and characterization of cells obtained from human solid tumors by mechanical and enzymatic means
24. A method for dissociation of viable human breast cancer cells that produces flow cytometric kinetic information similar to that obtained by thymidine labeling
25. Comparative flow DNA analysis of different cell suspensions in breast carcinoma
26. Implications of disaggregation procedures on biological representation of human solid tumors
27. Solid tumor preparation for clinical application of flow cytometry
28. Comparison of tissue disaggregation techniques of transitional cell bladder carcinomas for flow cytometry and chromosomal analysis
29. Caution on the use of lymphocytes as standards in the flow cytometric analysis of cultured cells
30. Changes in accessibility of DNA to various fluorochromes suring spermato‐genesis
31. Distinction of Leukocyte classes based on chromatin‐structure‐dependent DNA‐binding of 7‐Aminoactino‐mycin D
32. Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells
33. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience
34. The resolution of aneuploid DNA stemlines by flow cytometry: limitations by the coefficient of variation and the percentage of aneuploid nuclei
35. A simole and rapid method for determining the linearity of a flow cytometer amplification system
36. Improved prognostic impact of S‐phase values from paraffin‐embedded breast and prostate carcinomas after correcting for nuclear slicing
37. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry
38. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma